Penn helped test a promising mRNA cancer vaccine. Here’s what the trial means for the field.

Penn helped test an mRNA cancer vaccine that succeeded in its late-stage clinical trial. “This was kind of the wake-up call that RNA vaccines in cancer have an enormous future,” Drew Weissman said.